Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 4400 participants.
Also called NCT02579499
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 4,400 participants
- Sponsor
- Registry
-
NCT02579499
-
- Other papers using this trial's data
- Effect of rosuvastatin versus atorvastatin on new-onset diabetes mellitus in patients treated with high-intensity statin therapy for coronary artery disease: a post-hoc analysis from the LODESTAR randomized clinical trial
- Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial
- Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease: A Randomized Clinical Trial
- Treat-to-target or high-intensity statin treatment in older adults with coronary artery disease: a post hoc analysis of the LODESTAR trial
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT02579499. Randomized; no masking; primary purpose treatment. Start 2016-09-09 (actual); primary completion 2022-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease
- Acronym
- LODESTAR
- Condition
- Coronary Artery Diseasse
- Intervention (Drug)
- fixed high potent statin therapy
- Intervention (Drug)
- targeted LDL-C goal statin
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct02579499- Content hash
c8ae956546f9fc3345123870c23ab95e1550e42d2723a4e3201f2fd7b1d08177